NCT05269030: Ivermectin Nasal Drops in Post COVID-19 Parosmia
- State
- State not given
- Phase
- Phase 2
- People
- 60 planned
- Started
- Jul 2022
- Primary completion
- Mar 2023
- Arms
- Case group
- Results
- None posted
- 7 Mar 2022: Trial registered
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Also known as Acarexx, Bimectin, Bovinet, Cardomec, CARDOTEK 30, Cevamec, Equimec, Eqvalan, Heartgard, Hyvermectin, Ivectin, IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care., Ivertin, Ivomec, Ivosint, Ivermectin (IVM), Ivermectin 0.4mg/kg/day for 5 days, Ivermectin 3 MG, Ivermectin 3mg Tab, Ivermectin Injectable Product, Ivermectin Oral Product, Ivermectin Pill, Ivermectin Tablets, Ivermectin Topical, Ivermectin nasal, Ivermectin oral, Jetamec, Mectizan, Noramectin, Noromectin, Oramec, Pandex, Phoenectin, Sklice, Soolantra, Stromectol, Uvemec, Vermic, Vetmec, Zimecterin, intranasal ivermectin spray.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.